Ignite Creation Date:
2025-12-24 @ 7:07 PM
Ignite Modification Date:
2026-05-11 @ 7:46 PM
Study NCT ID:
NCT05738057
Status:
RECRUITING
Last Update Posted:
2023-11-29
First Post:
2023-02-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma
Sponsor:
Hua Li
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
[2023]02-116-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None